CORTISONE TREATMENT OF SARCOIDOSIS
- 2 October 1954
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 156 (5) , 461-466
- https://doi.org/10.1001/jama.1954.02950050001001
Abstract
Sarcoidosis is by no means a benign disease. Chronic disability is common, and blindness as a result of ocular involvement or death from progressive respiratory insufficiency may occur. There is need for a therapeutic agent, but trial of numerous drugs, antibiotics, and other agents was fruitless until the effectiveness of cortisone was shown.1 Other observers2 have also reported prompt and marked improvement during treatment with cortisone and adrenocorticotropic hormone. Objective evidence of the activity of these agents has been afforded by striking changes in histological appearance noted in serial biopsy studies3 as well as by respiratory function studies.4 However, relapse and even exacerbation have been noted when treatment was discontinued, and some observers have reported frequent activation of tuberculosis.5 Our experience with cortisone in therapy of sarcoidosis is with 36 patients, who have been observed for as long as 46 months after treatment. The resultsKeywords
This publication has 6 references indexed in Scilit:
- LOCAL INJECTION OF HYDROCORTISONE AND CORTISONE INTO SKIN LESIONS OF SARCOIDOSISJAMA, 1953
- THE RELATIONSHIP BETWEEN PERIARTERITIS NODOSA AND SARCOIDOSISAnnals of Internal Medicine, 1953
- DIFFUSE PULMONARY SARCOIDOSIS - DIFFUSING CAPACITY DURING EXERCISE AND OTHER LUNG FUNCTION STUDIES IN RELATION TO ACTH THERAPY1952
- THE EFFECTS OF ADRENOCORTICOTROPIC HORMONE (ACTH) AND CORTISONE ON SARCOIDOSIS1952
- ETIOLOGIC AND IMMUNOLOGIC CONCEPTS REGARDING SARCOIDOSISArchives of Dermatology, 1951
- Effect of Cortisone in SarcoidosisNew England Journal of Medicine, 1951